A new publication involving cosyntropin appeared in the journal Surgery, dated September 1, 2026. The paper is titled "The utility of cosyntropin stimulation test in the assessment of adrenal function after unilateral adrenalectomy." It was indexed under PubMed ID 42816228. The publication addresses the use of cosyntropin stimulation testing in evaluating adrenal function in patients who have undergone unilateral adrenalectomy. No findings, results, or conclusions from the study are described here. Cosyntropin remains an approved compound used in adrenal function assessment. This item reflects only the appearance of the publication and its listed title, journal, and date. Readers interested in the specific methods, patient outcomes, or data reported in the study should consult the publication directly. For general background on cosyntropin, including its approved uses and mechanism, readers can refer to the compound overview provided alongside this brief.
New Publication Examines Cosyntropin Stimulation Test Post-Adrenalectomy
See the full cosyntropin overview
Source: https://pubmed.ncbi.nlm.nih.gov/42816228/